NAMSA has extensive experience with Class II and Class III cardiac, cardiovascular, and neurovascular devices, such as ventricular assist devices, circulatory support, pacing devices, aneurysm stents and fillers, IVDs (cardiac markers), combination products and tissue/biologics.

We also have expertise with diagnostics, electrophysiology and interventional devices for other cardiology and cardio/neurovascular indications.

Our technical specialists and scientists are adept at developing preclinical testing programs for such products, our Veterinary surgeons are experienced at implanting and evaluating the biocompatibility and functionality of such devices, and our Consultants have conducted beneficial gap analyses and audits for many cardiac, cardio/peripheral vascular and neurovascular companies.

NAMSA, a leading contract research organization (CRO), has supported multiple US and OUS studies to treat vascular disease. NAMSA has supported hundreds of clinical studies ton cardiovascular devices.

Cardiovascular Projects

Within the last five years, NAMSA has preformed:

  • 250 Cardiovascular Projects
  • 50 Peripheral Vascular Projects
  • In 30 Countries
  • 800 Sites
  • 8000 Subjects
  • 5000 Monitoring Visits
  • 470 Databases Built/Managed
  • 500 Statistical Reports

Select Cardiovascular Experience

  • Left ventricular assist device (Adult & Pediatric LVAD)
  • Coronary saphenous vein grafts (SVG)
  • Cardiac Mapping Technologies
  • Counterpulsation pump device
  • Orbital atherectomy system
  • Cardiovascular device to treat hypertension
  • Left atrial appendage occlusion device
  • Therapeutic lead EP & intravascular ultrasound
  • Robotic ablation for Atrial fibrillation
  • ICD and RCT therapy
  • Heart failure devices
  • Therapeutic lead EP & intravascular ultrasound